ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE

Clinical trials for ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE explained in plain language.

Never miss a new study

Get alerted when new ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE trials appear

Sign up with your email to follow new studies for ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immunotherapy may replace chemo in anal cancer treatment

Disease control Recruiting now

This phase 3 trial tests whether the immunotherapy drug sintilimab can replace the chemotherapy drug mitomycin in standard chemoradiation for limited-stage anal squamous cell carcinoma. About 350 patients who have not yet been treated will receive either the standard regimen (rad…

Matched conditions: ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE

Phase: PHASE3 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE

Get alerted when new ANAL SQUAMOUS CELL CARCINOMA, LIMITED-STAGE trials appear

Immunotherapy may replace chemo in anal cancer treatment